Jazz Pharmaceuticals (JAZZ) Q3 2025 Earnings

5AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-8.25
-3.3
1.66
6.61

Details

Expected EPS
-7.606016
Actual EPS
-8.25
Surprise EPS
-0.64
Surprise Percent
+8.47%

Description

Jazz Pharmaceuticals (JAZZ) has reported earnings of -8.25 per share for Q3 2025.

0 Comments

Share your thoughts